EV/EBITDA:
10.88+0.13(+1.21%)Summary
- As of today (August 3, 2025), SUPN EV/EBITDA is 10.88, with a rise of +0.13 (+1.21%) during the most recent trading session on August 1, 2025.
- Over the past year, SUPN EV/EBITDA has dropped by -2.33 (-17.64%).
- SUPN EV/EBITDA is now -87.22% below its all-time high of 85.14.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | +1.2% | +1.2% | +1.2% |
1 m1 month | +12.2% | +12.2% | +11.6% |
3 m3 months | +9.9% | +9.9% | +9.4% |
6 m6 months | -7.8% | -9.5% | -7.5% |
ytdytd | -2.1% | -3.8% | -1.8% |
1 y1 year | -17.6% | +17.8% | +20.1% |
5 y5 years | +49.0% | +38.9% | +59.5% |
SUPN EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | 10.88 | at high | 9.58 | +13.6% |
3 m | 3-month | 10.88 | at high | 9.42 | +15.5% |
6 m | 6-month | 12.31 | -11.6% | 9.42 | +15.5% |
1 y | 1-year | 15.73 | -30.8% | 9.42 | +15.5% |
3 y | 3-year | 23.20 | -53.1% | 9.42 | +15.5% |
5 y | 5-year | 23.20 | -53.1% | 5.50 | +97.8% |
alltime | all time | 85.14 | -87.2% | -144.43 | +107.5% |
SUPN EV/EBITDA History
Date | Value |
---|---|
2025 | 10.88(-2.1%) |
2024 | 11.11(-35.4%) |
2023 | 17.21(+15.4%) |
2022 | 14.91(+8.4%) |
2021 | 13.75(+99.3%) |
2020 | 6.90(-15.4%) |
2019 | 8.16(-28.0%) |
Date | Value |
---|---|
2018 | 11.34(-35.7%) |
2017 | 17.63(-15.0%) |
2016 | 20.73(-33.4%) |
2015 | 31.14(-133.7%) |
2014 | -92.53(+2456.1%) |
2013 | -3.62(-25.1%) |
2012 | -4.83 |
FAQ
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SUPN is 10.88
What is the all time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high EV/EBITDA is 85.14
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals, Inc. EV/EBITDA has changed by -0.23 (-2.07%) since the beginning of the year
What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by -2.33 (-17.64%)